Search

Search Constraints

You searched for: Author/Creator Jain, Lokesh

Search Results

1. A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes. (April 2018)

2. A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation. (May 2020)

5. Canagliflozin use in patients with renal impairment—Utility of quantitative clinical pharmacology analyses in dose optimization. (16th February 2015)

6. Corrigendum to "A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" [Eur J Canc 131 (2020) 68–75]. (February 2021)